Product/Composition:- | Diclofenac Topical Gel |
---|---|
Strength:- | 1%, 2%, 4% |
Form:- | Topical Gel |
Reference Brands:- | Voltaren(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Diclofenac topical gel inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis, which decreases pain and inflammation locally. Benefits include targeted relief for musculoskeletal pain, arthritis, and sports injuries, fast absorption with minimal systemic side effects, providing effective, localized anti-inflammatory and analgesic action.
Diclofenac topical gel is approved in the EU and US for localized pain and inflammatory conditions. In the EU, brands like Voltaren are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and high manufacturing standards. In the US, FDA-approved Voltaren Gel and generics are backed by comprehensive clinical data and pharmacovigilance. Both regions require detailed dossiers for initial approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate efficient market entry for diclofenac topical gels, ensuring adherence to European and American standards for safe, effective anti-inflammatory therapy.